Pursuit of Sustainable Healthcare through Personalized Medicine with HPC

Print Friendly, PDF & Email

In this video from the HPC User Forum in Milwaukee, Graham Anthony from BioVista presents: Pursuit of Sustainable Healthcare through Personalized Medicine with HPC.

“We apply our systematic discovery platform to develop our pipeline of repositioned drug candidates in neurodegenerative diseases, epilepsy, oncology and orphan diseases. Our scientists use Biovista’s technology platform to analyze massive data resources and identify non-obvious, mechanism-of-action based associations between compounds, molecular targets and diseases. We use this insight to find new uses for existing drugs or drug combinations, assess their risk profile and advance them to PoC and Clinical Phase IIa/b sooner, cheaper and with a higher probability of success than has been possible to date.”

Graham Anthony is Biovista’s Chief Financial Officer & Chairman of its Advisory Board. In this role, Graham is involved in negotiating collaboration agreements, assessing new business opportunities, overseeing financial matters and coordinating Biovista’s response to investor interest. Graham was an early investor in Biovista and lead Biovista’s initial and subsequent financing rounds. Since 2000, both as an advisor and as a principal, Graham has assisted various firms in completing over 30 acquisitions, divestitures & fundraisings in a diverse range of industries. Recent investments include: TeamScreen, a business services firm using advanced web technologies to reduce costs & Greenlight Energy, a Wind Energy firm recently sold to BP. Graham has been a speaker on Mergers & Acquisitions and Benchmarking at various industry conferences. Early in his career, Graham founded, ran and sold two businesses: a small manufacturing firm and a regional newspaper. Graham received his MBA from the University of Virginia’s Darden School of Business, where he was awarded a Batten Fellowship. He holds a BA in English from the University of Virginia’s College of Arts & Sciences.